about
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancerPigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapyPotential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancerEstrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapyBiphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor betaNegative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cellsMolecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypesEstrogen biosynthesis and action in ovarian cancer.Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 CellsNew insights on the role of hormonal therapy in ovarian cancerModulation of estrogenic action in clear cell carcinoma of the ovary (Review).Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.Estrogen receptors and human disease: an update.Hormone response in ovarian cancer: time to reconsider as a clinical target?Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivoEstrogen and its receptors in cancer.Breast carcinoma cells in primary tumors and effusions have different gene array profiles.Endocrine therapy in epithelial ovarian cancer.Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.Endometriosis as a prognostic factor for cancer survival.Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality.A mouse model for endometrioid ovarian cancer arising from the distal oviduct.Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer.Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancerMechanisms for estrogen receptor expression in human cancer
P2860
Q24307419-1477A627-4845-49F5-A6B2-F5EF825289A5Q26777495-2A03432B-B0FD-45E5-8DA2-3A79FE032713Q27319512-A06B3B6A-3A54-4FAE-A94D-8C7F002BD43DQ28109453-9D997E3D-2DD4-4CFF-AC76-9F4FA7F9BE58Q33428431-B770311B-4780-41F9-A2E1-564FADFB1316Q33633056-87F60745-DA30-4B07-90C7-2EBC6B0081D4Q33642747-4330CB00-BFDB-4A4E-A6DC-7EB5D31B7C99Q33651509-DB8C51CE-BA4C-4C4E-B94C-5EB086E09535Q34199368-8EECBCE9-F7AD-49A1-B349-97B826C33ACAQ34496401-C6DAE4DC-7AD9-4271-BE16-25A851395C1AQ34524093-1AA95862-C71A-4DF1-B4A8-F4139EAF075EQ35510378-CE50DEF0-32BC-4085-A3F6-DBA5D7E77DB0Q35946017-365DECAF-9108-4F9C-9FB9-0C118056AEAEQ35959401-3A777506-5F0C-48EA-9DC2-D2C9C43FA45FQ36001247-4E30CAC1-BE53-4A9E-9A5E-8B7CABA530E1Q36224720-2A4430BA-F171-4B1B-95D4-41306000752FQ36243394-DED36CCD-7CB6-4CDD-98A6-2A0CF3ECBFAEQ36661810-F13DF5A6-0C40-48D7-9812-A61EFCEF89E5Q36966197-060F0BEF-541A-4404-A01A-2F28EB186C59Q36974565-586F4A95-7F34-4D00-B427-53E57EB98B21Q37222453-58707385-E0CF-4252-9CA3-142F4C9FAC28Q37301296-9B18FBD7-4DFA-4145-BA89-49F17B2BDA60Q39038223-5B628F3A-E6BF-4F43-8EAF-EDF071A052F7Q41585965-5C3A5D5D-7C74-4420-BACD-2881AFF31532Q45352511-3994BE83-81EB-4746-A439-695147ECD6F8Q45454238-10A7E60D-FDAE-4B5E-ABB3-2FBBB287F49EQ50107365-49F698BF-42F5-4EAE-B891-525F6E8BA46EQ54296090-AE96A235-F084-47D6-9941-210DB50B5347Q55228036-826904D2-61B0-4562-A5D7-7CA0E3E7DAA7Q55457293-08422F44-B919-46FB-BD9F-34078D49ED9FQ58710004-9062F2E1-91E7-4FDA-A153-ECE96F9B100FQ58718563-C5FC3570-A0C7-4BB5-85E0-B00F6B783479
P2860
description
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2008
@uk
name
Estrogen Receptor Subtypes in Ovarian Cancer
@en
Estrogen Receptor Subtypes in Ovarian Cancer
@nl
type
label
Estrogen Receptor Subtypes in Ovarian Cancer
@en
Estrogen Receptor Subtypes in Ovarian Cancer
@nl
prefLabel
Estrogen Receptor Subtypes in Ovarian Cancer
@en
Estrogen Receptor Subtypes in Ovarian Cancer
@nl
P2093
P50
P1476
Estrogen receptor subtypes in ovarian cancer: a clinical correlation
@en
P2093
Liao Xiao-Yun
Stephanie S Liu
P304
P356
10.1097/01.AOG.0000296715.07705.E9
P407
P577
2008-01-01T00:00:00Z